Skip to main content

Javier Hoyo Pérez

Institutions of which they are part

Administration and Management
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Projects

Activity and connectivity drive neuronal vulnerability and disease progression in Parkinson's disease

IP: Miquel Vila Bover
Collaborators: Joan Compte Barrón, Javier Hoyo Pérez, Gerard Roch Alba, Marta González Sepúlveda
Funding agency: Michael J. Fox Foundation
Funding: 1269495.05
Reference: ASAP_MJFF2021
Duration: 01/11/2021 - 31/10/2024

DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES

IP: Sara Marsal Barril
Collaborators: Antonio Julia Cano, Javier Hoyo Pérez, Elena Granell Pallares
Funding agency: EUROPEAN COMMISSION
Funding: 1122820
Reference: DOCTIS_H2020_SC1-BHC2019
Duration: 01/01/2020 - 31/12/2025

Related news

Researchers describe the molecular mechanisms by which the GBA gene, the main genetic risk factor, associates with the accumulation of α-synuclein in neurons.

Es tracta del projecte “New Nanotechnological Therapy for Parkinson’s disease: Nose to Brain Delivery of GBA-Polymer Nanoconjugates (nanoGBAtoBrain)”.

La primera jornada dedicada a aquesta malaltia organitzada pel Campus Vall d’Hebron ha reunit més de 150 assistents.

Related professionals

Maria Gutiérrez-San Miguel Guilera

Maria Gutiérrez-San Miguel Guilera

Read more
Maria Antònia Agustí Escasany

Maria Antònia Agustí Escasany

Head of group
Clinical Pharmacology
Read more
Rosa Domínguez Oronoz

Rosa Domínguez Oronoz

Read more
Inma Salomón Castaño

Inma Salomón Castaño

Cardiovascular Diseases
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.